1. Home
  2. YMT vs MIST Comparison

YMT vs MIST Comparison

Compare YMT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMT

Yimutian Inc. American Depositary Shares

N/A

Current Price

$1.04

Market Cap

187.6M

Sector

Technology

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.70

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
MIST
Founded
2011
2003
Country
China
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.6M
176.3M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
YMT
MIST
Price
$1.04
$1.70
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
356.8K
2.1M
Earning Date
06-09-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,502,945.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.63
52 Week High
$6.05
$3.06

Technical Indicators

Market Signals
Indicator
YMT
MIST
Relative Strength Index (RSI) 34.60 34.51
Support Level $0.85 $1.70
Resistance Level $1.84 $1.89
Average True Range (ATR) 0.20 0.10
MACD -0.11 -0.01
Stochastic Oscillator 21.11 2.86

Price Performance

Historical Comparison
YMT
MIST

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: